Metropolitan Life Insurance CO Alx Oncology Holdings Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $7,594 - $24,285	1,579 New	1,579 $23,000
Q2 2023 Aug 10, 2023	BUY	$4.37 - $9.56 $5,248 - $11,481	1,201 New	1,201 $9,000
Q4 2022 Jun 14, 2023	BUY	$9.51 - $12.95 $12,439 - $16,938	1,308 New	1,308 $14.7 Million
Q3 2022 Jun 14, 2023	BUY	$8.23 - $15.14 $10,764 - $19,803	1,308 New	1,308 $12.5 Million
Q3 2022 Mar 30, 2023	BUY	$8.23 - $15.14 $543 - $999	66 Added 5.31%	1,308 $12,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $10,764 - $19,803	1,308 New	1,308 $13,000
Q2 2022 Aug 11, 2022	SELL	$5.89 - $19.46 $7,315 - $24,169	-1,242 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$13.65 - $22.06 $16,953 - $27,398	1,242 New	1,242 $20,000
Q1 2022 Mar 30, 2023	SELL	$13.65 - $22.06 $54,122 - $87,467	-3,965 Reduced 76.15%	1,242 $20,000
Q1 2022 May 12, 2022	SELL	$13.65 - $22.06 $54,122 - $87,467	-3,965 Reduced 76.15%	1,242 $21,000
Q4 2021 Jun 21, 2023	BUY	$21.49 - $74.4 $111,898 - $387,400	5,207 New	5,207 $111,000
Q3 2021 Jun 21, 2023	BUY	$52.51 - $80.91 $273,419 - $421,298	5,207 New	5,207 $384,000
Q2 2021 Mar 30, 2023	BUY	$52.2 - $75.23 $13,206 - $19,033	253 Added 5.11%	5,207 $284,000
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $271,544 - $391,346	5,202 Added 104040.0%	5,207 $285,000
Q1 2021 Jun 26, 2023	BUY	$62.84 - $87.68 $311,309 - $434,366	4,954 New	4,954 $365 Million
Q1 2021 Mar 30, 2023	BUY	$62.84 - $87.68 $122,726 - $171,239	1,953 Added 65.08%	4,954 $365,000
Q1 2021 May 14, 2021	SELL	$62.84 - $87.68 $188,268 - $262,689	-2,996 Reduced 99.83%	5 $365,000
Q4 2020 Jun 22, 2023	BUY	$34.11 - $112.26 $102,364 - $336,892	3,001 New	3,001 $258,000
Q3 2020 Jun 26, 2023	BUY	$29.36 - $47.1 $88,109 - $141,347	3,001 New	3,001 $113,000
Q3 2020 Mar 30, 2023	BUY	$29.36 - $47.1 $49,706 - $79,740	1,693 Added 129.43%	3,001 $113,000
Q3 2020 Nov 13, 2020	BUY	$29.36 - $47.1 $88,109 - $141,347	3,001 New	3,001 $113,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

Ven Bio Partners LLC San Francisco, CA

9.7M
Shares

$17.8 Million
14.51% of portfolio
Tang Capital Management LLC San Diego, CA

4.2M
Shares

$7.69 Million
0.65% of portfolio
Vivo Capital, LLC Palo Alto, CA

4.03M
Shares

$7.38 Million
1.07% of portfolio
Redmile Group, LLC San Francisco, CA

3.84M
Shares

$7.02 Million
0.46% of portfolio
Black Rock Inc. New York, NY

2.69M
Shares

$4.92 Million
0.0% of portfolio

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account